Assignee
GENESENSE TECHNOLOGIES INC
CA·8 granted patents·5 pending applications·103 citations·filing 1997–2005
Top patents by PatentIndex Score
13 records- 0184US6121000AAntitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductaseGENESENSE TECHNOLOGIES INC·Filed 1999·Granted Sep 19, 2000·62 cites·11 claims
- 0259US6566514B1Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growthGENESENSE TECHNOLOGIES INC·Filed 1999·Granted May 20, 2003·16 cites·13 claims
- 0358US6593305B1Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductaseGENESENSE TECHNOLOGIES INC·Filed 1999·Granted Jul 15, 2003·11 cites·13 claims
- 0457US2007032442A1Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cellsGENESENSE TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 0550US6417169B1Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growthGENESENSE TECHNOLOGIES INC·Filed 1999·Granted Jul 9, 2002·7 cites·20 claims
- 0649US2008311126A1Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of CancerGENESENSE TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 0747US2003087866A1Suppression of malignancy utilizing ribonucleotide reductase R1GENESENSE TECHNOLOGIES INC·Filed 2002·Application pending·0 cites
- 0847US2002187954A1Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growthGENESENSE TECHNOLOGIES INC·Filed 2002·Application pending·0 cites
- 0944US2008255065A1Small Interfering Rna Molecules Against Ribonucleotide Reductase and Uses ThereofGENESENSE TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 1038US7087580B2Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growthGENESENSE TECHNOLOGIES INC·Filed 1999·Granted Aug 8, 2006·4 cites·40 claims
- 1136US6610539B1Antisense oligonucleotide sequences as inhibitors of microorganismsGENESENSE TECHNOLOGIES INC·Filed 1998·Granted Aug 26, 2003·3 cites·21 claims
- 1231US6472376B2Suppression of malignancy utilizing ribonucleotide reductase R1GENESENSE TECHNOLOGIES INC·Filed 1998·Granted Oct 29, 2002·0 cites·10 claims
- 1330US7223849B1Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growthGENESENSE TECHNOLOGIES INC·Filed 1997·Granted May 29, 2007·0 cites·52 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →